News

Significant Projected Growth in ALS Prevalence by 2040

Significant Projected Growth in ALS Prevalence by 2040

Projected Increase in ALS Prevalence

New research indicates a significant rise in the number of individuals diagnosed with amyotrophic lateral sclerosis (ALS) over the next decade and a half. This important study, funded and co-authored by the ALS Association, provides insights into how the prevalence of ALS is expected to change by 2040.

Key Findings from New Research

The study utilized quality registry data from a region in Italy, covering the years from 2005 to 2019, to track trends related to incidence, survival rates, and the overall number of people living with ALS. The analysis points to an alarming forecast that the total number of people affected by ALS could surge by 25% worldwide, influenced by factors such as an aging population and advancements in treatment.

The findings reveal that prevalence rates in the United States could jump from 9.68 per 100,000 in 2024 to 11.21 per 100,000 by 2040, which translates to nearly 9,000 additional cases across the nation. Should advancements in treatment lead to prolonged survival, the prevalence might escalate to as high as 12.01 per 100,000.

Implications for Healthcare Planning

Dr. Rosario Vasta, the lead author from the University of Turin, emphasizes that ALS, while traditionally viewed as a rare disorder, is poised to impact a larger segment of the population. This projected growth underscores the need for healthcare systems to reevaluate their resource allocation, research focus, and planning strategies to meet the needs of a growing ALS community.

Much of the projected increase in prevalence is attributed to enhancements in survival rates. Dr. Kuldip Dave from the ALS Association highlights the role of improved care and early diagnosis in contributing to longer life expectancy for those with ALS.

Improved Access and Awareness

According to Dr. Dave, there is a clear correlation between access to multidisciplinary care and enhanced survival, as early diagnosis and treatment enable individuals to make use of effective therapies when they are most beneficial. Greater awareness about ALS is critical in ensuring that more patients receive timely care and interventions.

Future Solutions and Tools

The researchers have developed an interactive online tool that allows users to forecast how changes in demographics, survival rates, and other dynamics may affect regional prevalence of ALS. This tool serves as a valuable resource for understanding the future landscape of ALS.

The ALS Association's strategic plan aims to directly address these challenges. With an expanding patient community, the organization is dedicated to implementing solutions that ensure individuals living with ALS receive affordable care and support, while actively working towards a cure.

Commitment to the ALS Community

As the situation evolves, the ALS Association remains committed to making living with ALS manageable until a cure is found. This urgency is reflected in Dr. Dave's remarks about the necessity for accessible care and support for the growing number of individuals affected by this relentless disease.

About the ALS Association

The ALS Association is recognized as the largest organization dedicated to ALS globally. Its mission focuses on funding research initiatives, providing assistance to those affected and their families across a vast network of care, and advocating for policies that enhance the lives of individuals with ALS.

Understanding ALS

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative condition impacting nerve cells in both the brain and spinal cord. The progression of ALS leads to a gradual loss of mobility, speech, and ultimately, the ability to breathe. As it stands, ALS is a fatal condition, often resulting in a life expectancy of around five years post-diagnosis. Due to the limited treatment options currently available, there remains a critical need for new therapies aimed at diminishing functional decline and managing disease progression.

Frequently Asked Questions

1. What is ALS?

Amyotrophic lateral sclerosis (ALS) is a progressive disease affecting nerve cells, leading to loss of movement and eventually death.

2. What does the new study indicate about ALS prevalence?

The study projects a 25% increase in ALS prevalence globally by 2040 due to an aging population and improved survival rates.

3. Who co-authored the new ALS study?

The study involved collaboration between researchers from the ALS Association and the University of Turin.

4. How can the public access information from the ALS study?

Researchers created an online tool that allows users to explore projected ALS prevalence changes.

5. What is the mission of the ALS Association?

The ALS Association aims to make living with ALS manageable and ultimately strives to find a cure.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Evotec’s Second IND Adds Proof to Its Glue Platform

Updated Category News Views 25

Two IND acceptances from one long-running alliance is not nothing, especially in a drug-discovery business where plenty of polished platform talk never makes it to the clinic. Evotec has cleared that modest but meaningful bar again with Bristol Myers Squibb: a second molecular-glue candidate has received FDA acceptance for an Investigational New Drug application. The...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 125

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital

Updated Category News Views 154

Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....

Continue Reading
WeWalk Brings Diabetes Support Back to Dubai Science Park

Updated Category News Views 32

Before sunrise on 21 November, a 3.5 km route in Dubai Science Park will carry a purpose bigger than sneakers and weekend fitness. WeWalk is returning for its seventh edition, with TECOM Group PJSC and Dubai Charity Association again putting the event behind support for children living with diabetes. That deserves to be said plainly: this is a community health effort, not...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 69

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 108

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 57

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Adecco Finds AI Value Depends on Better Work Redesign

Updated Category News Views 39

A shiny AI license is not a productivity strategy, and Adecco's latest workforce survey puts some hard numbers behind that irritation. The company surveyed 40,500 workers in 36 countries for its seventh Global Workforce of the Future report, released November 19, 2026. Its central finding is disarmingly sensible: AI produces more when companies rebuild the work around it...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 50

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 194

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Appian Partners with Children's National to Elevate Healthcare

Updated Category News Views 87

Appian Teams Up with Children’s National Hospital Appian, known for its cutting-edge software solutions, is excited to share its new collaboration with Children’s National Hospital, one of the top names in pediatric healthcare. This partnership aims to raise awareness and gather essential resources for children's health. Appian is dedicated to enhancing the healthcare...

Continue Reading
Deutsche Bank Predicts ECB Rate Cuts Amid Falling Inflation

Updated Category News Views 101

Deutsche Bank dropped a prediction back in late 2023 that the European Central Bank (ECB) was gearing up for interest rate cuts this October. Traders perked up when they caught wind of unexpected dips in inflation figures from the eurozone noted earlier that September. Why the Cut? Inflation Insights Unpacked Analysts at Deutsche Bank, led by chief economist Mark Wall,...

Continue Reading
Vipshop's Financial Performance Analysis for 2024 Revealed

Updated Category News Views 390

Vipshop's Financial Insights for 2024 Vipshop Holdings Limited (NYSE: VIPS), a prominent online discount retailer in the Chinese market, has recently shared its unaudited financial results for the quarter and full year that concluded on December 31, 2024. Despite encountering challenges over the previous year, Vipshop's performance indicates resilience and potential...

Continue Reading
Boston University and Infocap Partner for Digital Transformation

Updated Category News Views 207

Boston University's Digital Business Institute Partners with Infocap BOSTON--The Digital Business Institute (DBI) at Boston University Questrom School of Business and Infocap AI Corp, a leader in human-centric automation, have announced a strategic partnership aimed at revolutionizing digital transformation across the banking sector. This collaboration is particularly...

Continue Reading
Disclosure and Investment Position Overview for Keywords Studios

Updated Category News Views 116

Understanding Disclosure and Investment Positions In the complex world of stock market investments, transparency is crucial. This is especially true for organizations involved with Keywords Studios PLC, a leading player in the gaming services sector. This article seeks to shed light on the recent disclosures and key investments associated with this prominent company. Key...

Continue Reading